![Irinotecan EP Impurity L ;Irinotecan HCl USP C D ;Irinotecan Enantiomer (EP) ;Irinotecan HCl R-Isomer ;(R)-9-[(1,4'-Bipiperidine)-1'-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline hydrochloride](https://drjcrbio.com/wp-content/uploads/e12-1.png)
Irinotecan EP Impurity L ;Irinotecan HCl USP C D ;Irinotecan Enantiomer (EP) ;Irinotecan HCl R-Isomer ;(R)-9-[(1,4′-Bipiperidine)-1′-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline hydrochloride
Description
| Code: JCIRN-05 |
| CAS: |
| Chemical Formula: C33H39ClN4O6 |
| Molecular Weight: 623.14 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Irinotecan EP Impurity L ;Irinotecan HCl USP C D ;Irinotecan Enantiomer (EP) ;Irinotecan HCl R-Isomer ;(R)-9-[(1,4′-Bipiperidine)-1′-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline hydrochloride is useful as reference Impurity standard |
